This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Darwin Asa, Ph.D
Global Market Development Manager - Nucleic Acid Therapeutics at Thermo Fisher Scientific


Dr. Darwin Asa received his BS in Honors Biology from the University of Michigan-Flint and PhD in Biochemistry from the University of Illinois. He did post-doctoral work in both biotech and pharmaceutical companies. Over the course of his almost 30 year career, he has held a variety of research, product development and marketing positions. Dr. Asa has worked in a wide range of research fields including Cell and Molecular Biology, Genomics, Proteomics and Analytical Chemistry. He has also managed several products and technologies used in the process and analytical development of pharmaceuticals. His experience includes work on a number of products and technologies in Clinical Diagnostics products in Oncology, Clinical Chemistry, and Microbiology as well. He recently joined Thermo Fisher Scientific and is currently the Global Market Development Manager for Nucleic Acid Therapeutics, responsible for many of the materials used in development and manufacturing of oligonucleotide therapeutics and mRNA vaccines.

Agenda Sessions

  • Technical Panel: mRNA Production - Common Questions and Solutions- ROOM 101